Get started
Author

R Delwel

Observed names: Delwel, R., R. Delwel, Rudd Delwel
OpenAlex ID: A5110470996
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
2008 · R. G.W. Verhaak, B. J. Wouters, et al. · Haematologica · 360
PDF
Mutations in N-ras predominate in acute myeloid leukemia
1987 · JL Bos, M Verlaan-de Vries, et al. · Blood · 235
PDF
Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response
1989 · LM Budel, IP Touw, et al. · Blood · 134
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
2008 · M. E.D. Chamuleau, A. A. van de Loosdrecht, et al. · Haematologica · 98
PDF
Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo
2008 · H C Suh, W Leeanansaksiri, et al. · Oncogene · 59
Tumor necrosis factor regulates the expression of granulocyte- macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells
1991 · O Elbaz, LM Budel, et al. · Blood · 57
PDF
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice
2000 · D Louz, M van den Broek, et al. · Leukemia · 49
Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor.
1990 · M Salem, R Delwel, et al. · PubMed · 41
Gene structure, expression profiling and mutation analysis of the tumour suppressor SHIP1 in Caucasian acute myeloid leukaemia
2007 · D C Gilby, A C Goodeve, et al. · Leukemia · 31
Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5.
1991 · I Touw, J Donath, et al. · PubMed · 30
Tribbles Homolog 2 (Trib2) Inactivates C/EBPalpha and Causes Acute Myelogenous Leukemia.
2006 · Karen Keeshan, Yiping He, et al. · Blood · 21
Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
1993 · L M Budel, R Delwel, et al. · PubMed · 18
The gene signature in CCAAT-enhancer-binding protein dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors
2013 · A. Liss, C.-H. Ooi, et al. · Haematologica · 16
PDF
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome (vol 93, pg 1894, 2008)
2009 · Chamuleau, M.E.D., Loosdrecht, A.A. van de, et al. · Pure Amsterdam UMC · 3
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia: A study of 6,515 cases of AML
2010 · Groeschel, S., Lugthart, S., et al. · University of Groningen research database (University of Groningen / Centre for Information Technology) · 1
Activated RAS Oncogenes in Acute Leukemia
1986 · J. L. Bos, M. Verlaan-de Vries, et al. · Springer eBooks · 1
Improved Copy Number Variation Estimation From Next Generation Sequencing Data Reveals Focal Genetic Lesions Such as Mll-ptd in Acute Myeloid Leukemia
2014 · Sanders, Remco M. Hoogenboezem, et al. · Data Archiving and Networked Services (DANS)
A Study on the Clinical Significance of the Who Aml Subtype Inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Chromosomal Abnormalities in 6,819 Aml Cases
2010 · Sanne Lugthart, Samuel Groeschel, et al. · IRIS
Evi1 Overexpression Is Associated with Unfavorable Subtypes in Pediatric Acute Myeloid Leukemia
2009 · Brian V. Balgobind, Sanne Lugthart, et al. · Pure Amsterdam UMC
Nm23-M2 is frequently mutated in leukemia A novel mechanism of disregulated expression
2000 · Marieke Joosten, Y. Vankan Berkhoudt, et al.
Works count: 21
Citation count: 1,154
H-index: 13
I10-index: 13
Year
Topic
Type